Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for BioRestorative Therapies (BRTX) over the last 10 years, with Q3 2025 value amounting to -$1600.0.

  • BioRestorative Therapies' Change in Receivables fell 10116.28% to -$1600.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$151600.0, marking a year-over-year decrease of 22060.46%. This contributed to the annual value of $169100.0 for FY2024, which is 502424.24% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Change in Receivables of -$1600.0 as of Q3 2025, which was down 10116.28% from -$10000.0 recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Change in Receivables high stood at $137600.0 for Q3 2024, and its period low was -$163400.0 during Q1 2025.
  • In the last 5 years, BioRestorative Therapies' Change in Receivables had a median value of -$2300.0 in 2021 and averaged -$787.5.
  • Per our database at Business Quant, BioRestorative Therapies' Change in Receivables soared by 100000.0% in 2022 and then crashed by 114076.43% in 2025.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Change in Receivables stood at -$3000.0 in 2021, then plummeted by 866.67% to -$29000.0 in 2022, then skyrocketed by 31.03% to -$20000.0 in 2023, then surged by 217.0% to $23400.0 in 2024, then tumbled by 106.84% to -$1600.0 in 2025.
  • Its Change in Receivables stands at -$1600.0 for Q3 2025, versus -$10000.0 for Q2 2025 and -$163400.0 for Q1 2025.